- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Kassel, Universität Kassel, Dissertation, 2019
- Keyword
-
Parkinson-Krankheit
Leucin
Kinasen
- Event
-
Veröffentlichung
- (where)
-
Kassel
- (who)
-
Universitätsbibliothek Kassel
- (when)
-
2020
- Creator
-
Schmidt, Sven
- DOI
-
10.17170/kobra-20190925703
- URN
-
urn:nbn:de:101:1-2021042910254073817697
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schmidt, Sven
- Universitätsbibliothek Kassel
Time of origin
- 2020
Other Objects (12)
Exosome markers of LRRK2 kinase inhibition
Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
RedOx regulation of LRRK2 kinase activity by active site cysteines
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Exosome markers of LRRK2 kinase inhibition
Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
RedOx regulation of LRRK2 kinase activity by active site cysteines
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
Fibroblast Biomarkers of Sporadic Parkinson’s Disease and LRRK2 Kinase Inhibition
Exosome markers of LRRK2 kinase inhibition
Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein Destabilization
G2019S selective LRRK2 kinase inhibitor abrogates mitochondrial DNA damage
LRRK2 kinase regulates α-synuclein propagation via RAB35 phosphorylation
Rab29 activation of the Parkinson's disease‐associated LRRK2 kinase
Functional characterization of leucine-rich repeat kinase 2 (LRRK2) dimerization
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
Interferon gamma induces leucine-rich repeat kinase LRRK2 via extracellular signal-regulated kinase ERK5
RedOx regulation of LRRK2 kinase activity by active site cysteines
LRRK2 kinase inhibition reverses G2019S mutation-dependent effects on tau pathology progression
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia